Nexalin Technology (NXL) Free Cash Flow (2021 - 2026)
Nexalin Technology (NXL) posted quarterly Free Cash Flow of -$1.8 million for Q1 2026, down 23.56% year-over-year from -$2.3 million in Q1 2025, and down 53.5% quarter-over-quarter from -$1.1 million in Q4 2025.
Nexalin Technology (NXL) Free Cash Flow (2021 - 2026) Analysis & Trends
Nexalin Technology's Free Cash Flow history runs 6 years deep, the most recent figure standing at -$1.8 million for Q1 2026.
- In Q1 2026, Free Cash Flow fell 23.56% year-over-year to -$1.8 million; the TTM figure through Mar 2026 stood at -$5.3 million (down 14.9% YoY), while the FY2025 annual figure was -$5.0 million, down 25.69% from the prior year.
- Free Cash Flow for Q1 2026 stood at -$1.8 million, down from -$1.1 million in the prior quarter.
- The five-year high for Free Cash Flow was -$162272.0 in Q2 2022, with the low at -$1.8 million in Q1 2026.
- The 5-year median for Free Cash Flow is -$943699.0 (2022), against an average of -$983258.5.
- The sharpest annual moves came in 2023 and 2024: Free Cash Flow plunged 546.75% in 2023, then soared 41.94% in 2024.
- Nexalin Technology's Free Cash Flow stood at -$906457.0 in 2022, then fell by 10.76% to -$1.0 million in 2023, then decreased by 12.99% to -$1.1 million in 2024, then dropped by 1.19% to -$1.1 million in 2025, then plunged by 53.5% to -$1.8 million in 2026.
- Business Quant data shows NXL's Free Cash Flow at -$1.8 million in Q1 2026, -$1.1 million in Q4 2025, and -$1.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 1.99 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 1.06 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 2.09 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 1.28 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 585.00 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 184.50 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 68.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 511.44 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 279.60 Mn |
| 10 | Nexalin Technology | 7.04 Mn | 6.03 Mn | 8,897.00 | -1.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.80 Mn |
| Jun 30, 2026 | -1.80 Mn |
| Mar 31, 2026 | -1.76 Mn |
| Mar 31, 2026 | -1.76 Mn |
| Dec 31, 2025 | -1.15 Mn |
| Dec 31, 2025 | -1.15 Mn |
| Sep 30, 2025 | -1.47 Mn |
| Sep 30, 2025 | -1.47 Mn |
| Jun 30, 2025 | -917,165.00 |
| Jun 30, 2025 | -917,165.00 |
| Mar 31, 2025 | -1.43 Mn |
| Mar 31, 2025 | -1.43 Mn |
| Dec 31, 2024 | -1.13 Mn |
| Dec 31, 2024 | -1.13 Mn |
| Sep 30, 2024 | -800,210.00 |
| Sep 30, 2024 | -800,210.00 |
| Jun 30, 2024 | -1.25 Mn |
| Jun 30, 2024 | -1.25 Mn |
| Mar 31, 2024 | -763,289.00 |
| Mar 31, 2024 | -763,289.00 |